Nasonal 1 Mg/Ml (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. By stimulating alpha‑1 receptors on the blood vessels of the nasal mucosa, it causes vasoconstriction, which reduces blood flow, edema, and congestion, allowing the nasal passages to open.

The appropriate dose of Nasonal 1 Mg/Ml is determined by a qualified prescriber based on the patient’s age, condition, and response. Typically, a few sprays per nostril are used, but exact instructions should follow the healthcare professional’s recommendation.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nasonal’s active ingredient, Xylometazoline Hydrochloride, belongs to the imidazoline class, offering rapid vasoconstriction similar to phenylephrine‑based sprays. Compared with oxymetazoline, it has a comparable onset but may have a slightly shorter duration, making it suitable for short‑term relief.

Store Nasonal 1 Mg/Ml at room temperature, below 25 °C, in its original packaging. Protect the container from moisture, direct sunlight, and extreme heat to maintain product stability.

Nasonal is a nasal solution intended for intranasal use. The prescribed number of sprays is applied into each nostril, usually while the head is upright. The patient should avoid blowing the nose immediately after administration to allow optimal absorption.

Serious risks, though rare, include severe hypertension, cardiac arrhythmias, nasal septum perforation from prolonged misuse, and anaphylactic reactions. Users should discontinue the product and seek medical attention if they experience symptoms such as a rapid rise in blood pressure, chest pain, or severe allergic signs.

Individuals with known hypersensitivity to Xylometazoline Hydrochloride or any component of the formulation should avoid use. Patients with uncontrolled hypertension, severe cardiovascular disease, or those taking MAO inhibitors should consult a healthcare professional before using the product.